138 related articles for article (PubMed ID: 37403871)
1. Determining Percentiles of Atherosclerotic Cardiovascular Risk According to Sex and Age in a Healthy Brazilian Population.
Cesena FY; Kashiwagi NM; Minanni CA; Santos RD
Arq Bras Cardiol; 2023 Jun; 120(6):e20220552. PubMed ID: 37403871
[TBL] [Abstract][Full Text] [Related]
2. Percentiles of predicted 10-year cardiovascular disease risk by sex and age in Brazil and their association with estimated risk of long-term atherosclerotic events.
Cesena FY; Generoso G; Santos IS; Duncan BB; Ribeiro ALP; Brant LC; Mill JG; Pereira AC; Bittencourt MS; Santos RD; Lotufo PA; Benseñor IM
Prev Med; 2023 Dec; 177():107755. PubMed ID: 37931661
[TBL] [Abstract][Full Text] [Related]
3. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
Wong ND; Fan W; Hu X; Ballantyne C; Hoodgeveen RC; Tsai MY; Browne A; Budoff MJ
J Am Coll Cardiol; 2024 Apr; 83(16):1511-1525. PubMed ID: 38631771
[TBL] [Abstract][Full Text] [Related]
5. Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles.
Navar AM; Pencina MJ; Mulder H; Elias P; Peterson ED
Am Heart J; 2018 Apr; 198():18-24. PubMed ID: 29653642
[TBL] [Abstract][Full Text] [Related]
6. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
[TBL] [Abstract][Full Text] [Related]
9. Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis.
Cao J; Remaley AT; Guan W; Devaraj S; Tsai MY
Atherosclerosis; 2021 Jun; 327():1-4. PubMed ID: 34004482
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
Patel KK; Taksler GB; Hu B; Rothberg MB
Ann Intern Med; 2017 Jun; 166(12):876-882. PubMed ID: 28505660
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.
Cesena FHY; Valente VA; Santos RD; Bittencourt MS
Arq Bras Cardiol; 2020 Sep; 115(3):440-449. PubMed ID: 33027365
[TBL] [Abstract][Full Text] [Related]
12. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
Fan W; Philip S; Granowitz C; Toth PP; Wong ND
Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
[TBL] [Abstract][Full Text] [Related]
13. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
[TBL] [Abstract][Full Text] [Related]
14. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
[TBL] [Abstract][Full Text] [Related]
15. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
[TBL] [Abstract][Full Text] [Related]
16. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
Mortensen MB; Afzal S; Nordestgaard BG; Falk E
J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
[TBL] [Abstract][Full Text] [Related]
17. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.
Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y
Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001
[TBL] [Abstract][Full Text] [Related]
18. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
19. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
Mortensen MB; Nordestgaard BG
JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
[TBL] [Abstract][Full Text] [Related]
20. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
